Targeting Protein Kinases for Cancer Therapy

This book PDF is perfect for those who love Medical genre, written by David J. Matthews and published by John Wiley & Sons which was released on 20 September 2011 with total hardcover pages 720. You could read this book directly on your devices with pdf, epub and kindle format, check detail and related Targeting Protein Kinases for Cancer Therapy books below.

Targeting Protein Kinases for Cancer Therapy
Author : David J. Matthews
File Size : 42,5 Mb
Publisher : John Wiley & Sons
Language : English
Release Date : 20 September 2011
ISBN : 9781118210772
Pages : 720 pages
Get Book

Targeting Protein Kinases for Cancer Therapy by David J. Matthews Book PDF Summary

An expert guide to targeting protein kinases in cancertherapy Research has shown that protein kinases can instigate theformation and spread of cancer when they transmit faulty signalsinside cells. Because of this fact, pharmaceutical scientists havetargeted kinases for intensive study, and have been working todevelop medicinal roadblocks to sever their malignant means ofcommunication. Complete with full-color presentations, Targeting ProteinKinases for Cancer Therapy defines the structural features ofprotein kinases and examines their cellular functions. Combiningkinase biology with chemistry and pharmacology applications, thisbook enlists emerging data to drive the discovery of newcancer-fighting drugs. Valuable information includes: Comprehensive overviews of the major kinase families involved inoncology, integrating protein structure and function, and providingimportant tools to assist pharmaceutical researchers to understandand work in this dynamic area of cancer drug research Focus on small molecule inhibitors as well as other therapeuticmodalities Discussion of kinase inhibitors that have entered clinicaltrials for the treatment of cancer, with an emphasis on moleculesthat have progressed to late stage clinical trials and, in a fewcases, to market Providing a platform for further study, this important workreviews both the successes and challenges of kinase inhibitortherapy, and provides insight into future directions in the waragainst cancer.

Targeting Protein Kinases for Cancer Therapy

An expert guide to targeting protein kinases in cancertherapy Research has shown that protein kinases can instigate theformation and spread of cancer when they transmit faulty signalsinside cells. Because of this fact, pharmaceutical scientists havetargeted kinases for intensive study, and have been working todevelop medicinal roadblocks to sever their malignant

Get Book
Protein Tyrosine Kinases

Leading researchers, from the Novartis group that pioneered Gleevec/GlivecTM and around the world, comprehensively survey the state of the art in the drug discovery processes (bio- and chemoinformatics, structural biology, profiling, generation of resistance, etc.) aimed at generating PTK inhibitors for the treatment of various diseases, including cancer. Highlights

Get Book
Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy

Tyrosine Kinase Inhibitors as Sensitizing Agents for Chemotherapy, the fourth volume in the Cancer Sensitizing Agents for Chemotherapy Series, focuses on strategic combination therapies that involve a variety of tyrosine kinase inhibitors working together to overcome multi-drug resistance in cancer cells. The book discusses several tyrosine kinase inhibitors that have

Get Book
Protein Kinases

For the past two decades, the protein kinase family has been an intense area of research for developing anticancer drugs. Despite tremendous advancements in kinase drug expansion, many kinases are still unexplored. As such, this book includes research and review articles from experts that focus on protein kinase signalling pathways

Get Book
Protein Kinase C in Cancer Signaling and Therapy

Protein kinase C (PKC), a family of serine-threonine kinases, rocketed to the forefront of the cancer research field in the early 1980’s with its identification as an effector of phorbol esters, natural products with tumor promoting activity. Phorbol esters had long been of interest to the cancer research field due

Get Book
Tyrosine Kinases as Druggable Targets in Cancer

Protein tyrosine kinase (PTK) deregulation contributes to growth of cancer and many other diseases. The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the deregulated PTKs, such as epidermal growth factor receptor (EGFR) in non-small-cell lung cancer (NSCLC) and Bcr-ABL in chronic myeloid leukemia (CML), has revolutionized disease management.

Get Book
Signalling Molecules as Targets in Cancer Therapy

This book presents state-of-the-art information on the molecules of cell signalling pathways that represent actual or future targets for cancer therapy. By giving an update of the most promising approaches in this rapidly evolving field, the book contributes to the translation of the recent advances in the knowledge of intracellular

Get Book
Kinase Drug Discovery

Kinase drug discovery remains an area of significant interest across academia and in the pharmaceutical industry. There are now around 13 FDA approved small molecule drugs which target kinases and many more compounds in various stages of clinical development. Although there have been a number of reviews/publications on kinase research,

Get Book